Association of Mandatory-Access Prescription Drug Monitoring Programs With Opioid Prescriptions Among Medicare Patients Treated by a Medical or Hematologic Oncologist

More than 30 states have enacted laws mandating use of prescription drug monitoring programs (PDMP) to reduce inappropriate opioid prescribing. Clinicians in those states must check the PDMP database before writing opioid prescriptions. These mandates vary substantially across states in their timing and scope; for example, some exempt patients with cancer.1,2 We examine the association between state mandatory-access PDMPs and changes in the percent of oncologists’ Medicare patients with any opioid prescription fills.

View Content

Contact

CHIME Opioid Action Center

710 Avis Drive, Suite 200
Ann Arbor, MI 48108

 

Phone: 1.734.665.0000

 

Questions, comments? Submit your feedback below!
  • This field is for validation purposes and should be left unchanged.